Bara Vaida (@barav) is AHCJ's core topic leader on infectious diseases. An independent journalist, she has written extensively about health policy and infectious diseases. Her work has appeared in the National Journal, Agence France-Presse, Bloomberg News, McClatchy News Service, MSNBC, NPR, Politico, The Washington Post and other outlets.
In early October, the U.S. Food and Drug Administration approved Paratek Pharmaceuticals’ new antibiotic Nuzyra, which kills bacteria associated with skin and lung infections.
The approval was notable because there are so few new antibiotics coming onto the market, , says journalist Maryn McKenna in Wired magazine, largely because most drug companies don’t think antibiotics — which have wiped out the threat of many infectious diseases — to be worth the investment.
For three years, the Centers for Medicare & Medicaid Services (CMS) have penalized hospitals when the institutions show unacceptably high rates of potentially avoidable complications, such as blood clots, bed sores, and infections, Jordan Rau reported last month for Kaiser Health News.
The federal agency this year added penalties for two hospital-acquired infections that result from germs resistant to antibiotics: methicillin-resistant Staphylococcus aureus (known as MRSA) and Clostridium difficile (C. diff). Continue reading →
As senior quality editor for HealthLeaders Media for more than six years, Cheryl Clark wrote more than 1,300 stories about hospitals’ efforts to improve quality and safety and related issues.
Rates of sepsis seemed to be one more dirty little hospital horror to explore, one that the Joint Commission said cost hospitals about $16.7 billion annually. Yet hospitals’ efforts to tackle it seemed hidden behind improvement initiatives attracting more attention, such as reducing hospital-acquired infections, and preventable readmissions, lowering emergency room wait times and raising patient experience scores.
The story she wrote for the June 2014 issue of HealthLeaders’ print magazine, on how U.S. hospitals are improving recognition and treatment of sepsis — which is diagnosed in 750,000 patients a year and kills 40 percent — won the 2015 National Institute of Health Care Management prize in the trade print category. They said the story was “most likely to save a life.”
Liz Seegert (@lseegert), is AHCJ’s topic leader on aging. Her work has appeared in NextAvenue.com, Journal of Active Aging, Cancer Today, Kaiser Health News and other outlets. She is a senior fellow at the Center for Health Policy and Media Engagement at George Washington University and co-produces the HealthCetera podcast.
Researchers from Columbia University School of Nursing and RAND Corporation analyzed infections in nursing homes over a five-year period from 2006-2010, using Minimum Data Set assessment data – the information submitted by the facilities to the Centers for Medicare and Medicaid. They found significantly increased infection rates for pneumonia, urinary tract infections (UTIs), viral hepatitis, septicemia, wound infections, and multiple drug-resistant organisms (MDROs), conditions that raise the risk of complications and death. Only tuberculosis rates did not show an increase.
Approximately 1.6 million to 3.8 million infections occur among U.S. nursing home residents each year. The new study found that UTIs remain, by far, the most frequently reported type of infection, but they also showed the smallest rise in prevalence – just 1 percent. Pneumonia was the second most common infection, and its prevalence rose 11 percent from 2006 to 2010. Infection rates increased 69.7 percent for viral hepatitis, 25.2 percent for septicemia, 24.1 percent for pneumonia, 15.7 percent for MDRO and 4.6 percent for wound infections.
Jackson found that inspections, by CMS and the FDA, have repeatedly turned up systemic practices that compromised patient safety. At the same time, the Joint Commission awarded the hospital a full accreditation, raising questions about why the agencies don’t share information.